Abstract
PURPOSE: An interval of six to eight weeks between completion of preoperative chemoradiation therapy and surgical resection of advanced rectal cancer has been described. Our purpose was to determine whether a longer time interval between completion of therapy and resection increases tumor downstaging and affects perioperative morbidity. METHODS: Forty patients with advanced adenocarcinoma of the rectum underwent preoperative chemoradiation on a prospective trial with irinotecan (50 mg/m2), 5-fluorouracil (225 mg/m2), and concomitant external-beam radiation (45–54 Gy) followed by complete surgical resection of the tumor with total mesorectal excision. The time interval between completion of chemoradiation and surgical resection ranged from 28 to 97 days. The patients were divided into two groups with 33 eligible patients: Group A (4-week to 8-week time interval; 28–56 days) and Group B (10-week to 14-week interval; 67–97 days). Tumor downstaging was compared between these two groups. The number of patients downstaged by at least one T stage, those downstaged by at least one N stage, those with pathologic complete responses, and those with only residual microscopic tumor foci were compared. Postoperative length of stay, estimated blood loss, perioperative morbidity, and sphincter-sparing procedures were also compared. Chi-squared tests and Student’s t-test were calculated. RESULTS: Group A had 19 patients, and Group B had 14 patients. Patient demographics were comparable. Mean age was 52 years, and 70 percent of patients were male. There were no deaths. There were no statistical differences in perioperative morbidity, with three anastomotic leaks in Group A. Tumors were downstaged in 58 percent of patients in Group A and 43 percent of those in Group B (P = 0.61). Nodal downstaging occurred in 78 percent of Group A and 67 percent of Group B (P = 0.9). The pathologic complete response rate was 21 percent in Group A and 14 percent in Group B (P = 0.97), and a residual microfocus of tumor was found in 33 percent of patients in Group A and 42 percent of those in Group B (P = 0.90). These differences were not statistically significant. CONCLUSIONS: Perioperative morbidity is not affected by longer intervals. A longer interval between completion of neoadjuvant chemoradiation and surgical resection may not increase the tumor response rate of advanced rectal cancer in this cohort.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
NA Janjan VS Khoo J Abbruzzese et al. (1999) ArticleTitleTumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer Int J Rad Oncol Biol Phys 44 1027–1038
JF Bosset V Magnin P Maingon et al. (2000) ArticleTitlePreoperative radiochemotherapy in rectal cancer Int J Rad Oncol Biol Phys 46 323–327
NA Janjan C Crane BW Feig et al. (2001) ArticleTitleImproved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer Am J Clin Oncol 24 107–112
S Pucciarelli ML Friso P Toppan et al. (2000) ArticleTitlePreoperative combined radiotherapy and chemotherapy for middle and lower rectal cancer Ann Surg Oncol 7 38–44
WE Enker N Mercheant AM Cohen et al. (1999) ArticleTitleSafety and efficacy of low anterior resection for rectal cancer Ann Surg 230 544–554
Y Francois CJ Nemoz J Baulieux et al. (1999) ArticleTitleInfluence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer J Clin Oncol 17 2396–2402
J Papillon (1987) ArticleTitleThe future of external beam irradiation as initial treatment of rectal cancer Br J Surg 74 449–454
. Anonymous (1997) ArticleTitleImproved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial N Engl J Med 336 980–987
B Glimelius U Isacsson B Jung et al. (1997) ArticleTitleRadiotherapy in addition to radical surgery in rectal cancer Int J Rad Oncol Biol Phys 37 281–287
JD Brierley BJ Cummings CS Wong et al. (1995) ArticleTitleAdenocarcinoma of the rectum treated by radical external radiation therapy Int J Rad Oncol Biol Phys 31 225–259
JE Krook CG Moertel LL Gunderson et al. (1991) ArticleTitleEffective surgical adjuvant therapy for high risk rectal carcinoma N Engl J Med 324 709–715
GM Videtic BJ Fisher FE Perera et al. (1998) ArticleTitlePreoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer Int J Rad Oncol Biol Phys 42 319–324
E Kapiteijn CA Marijnen ID Nagtegaal et al. (2001) ArticleTitleDutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med 345 638–646
A D’Amico W McKenna (1994) ArticleTitleApoptosis and a re-investigation of the biologic basis for cancer therapy Radiother Oncol 33 3–10
LH Thompson HD Suit (1969) ArticleTitleProliferation kinetics of x-irradiated mouse L cells studied with time-lapse photography. II Int J Rad Biol 15 347–362
Author information
Authors and Affiliations
About this article
Cite this article
Stein, D.E., Mahmoud, N.N., Anné, P.R. et al. Longer Time Interval Between Completion of Neoadjuvant Chemoradiation and Surgical Resection Does Not Improve Downstaging of Rectal Carcinoma. Dis Colon Rectum 46, 448–453 (2003). https://doi.org/10.1007/s10350-004-6579-0
Issue Date:
DOI: https://doi.org/10.1007/s10350-004-6579-0